Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 6—June 2007


Economic Evaluation and Catheter-related Bloodstream Infections

Kate Halton*†Comments to Author  and Nicholas Graves*†
Author affiliations: *The Centre for Healthcare Related Infection Surveillance and Prevention, Brisbane, Queensland, Australia; †Queensland University of Technology, Brisbane, Queensland, Australia

Main Article

Table 1

Inclusion and exclusion criteria for review

Inclusion criteria
  Had a full publication or manuscript for review
  Conducted a full economic evaluation which valued both costs and benefits of the intervention
  Based on a decision-analytic model
  Evaluated at least 1 infection-control intervention aimed at reducing incidence of catheter-related bloodstream infection relative to a baseline scenario
  Evaluated the intervention with respect to short-term (<21 d), nontunneled, central venous catheters
  Based in an adult patient population
  Written in English
Exclusion criteria
  Cost-analysis studies only
  Did not use a comparator
  Based on a clinical trial (e.g., randomized controlled trial or pre-post intervention study) or a case study
  Did not contain an original analysis (e.g., editorials, reviews)
  Contained purely hypothetical data (e.g., methods articles)
  Did not provide full details on methods (e.g., letters)
  Based in a pediatric patient population
  Evaluated interventions aimed at long-term or tunneled or peripherally placed central venous catheters
  Evaluated therapeutic or diagnostic interventions, as opposed to preventive interventions

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO